30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Foresite Capital Management IV, LLC

Insider profile

Performance

Overall performance
2.1

Performance over holding periods
2.1
30 days 90 days 120 days
Average return 32% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Foresite Capital Management IV, LLC's trades of Eikon Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-06 2026-02-04 B Purchase
33,439 -38.2%
159.84
US$2,732,936
33,439 -38.2% 159.84 US$2,732,936
2023-05-10 2023-05-08 B Purchase
98,802 +47.6%
299.87
US$2,730,835
98,802 +47.6% 299.87 US$2,730,835
2023-05-10 2023-05-08 B Purchase
80,978 +40.7%
436.51
US$1,185,047
80,978 +40.7% 436.51 US$1,185,047